Inhibitory signal pathways identified

May 8, 2017
Inhibitory signal pathways identified
An atherosclerotic lesion in the mouse. Credit: Döring Research Group

LMU researchers led by Christian Weber show that the chemokine receptor CXCR4 protects the integrity of arterial walls, and define a new mechanism that restricts the deleterious accumulation of cholesterol in atherosclerotic plaques.

Atherosclerosis is characterized by the build-up of fat-rich deposits on the inner surfaces of the endothelial that form the walls of the blood vessels. The presence of these atherosclerotic "plaques" leads to a chronic inflammation reaction, which can ultimately result in constriction of the vessel and the obstruction of blood flow in major arteries. Research teams led by Professor Christian Weber, Director of the Institute for Prophylaxis and Epidemiology of Cardiovascular Diseases (IPEK) at the LMU Medical Center, have long focused their efforts on understanding the molecular mechanisms that underlie the pathogenesis and progression of the disorder. In two new studies, which appear in the journal Circulation, he and his colleagues now describe two previously unknown mechanisms that help to retard the formation of .

The CXCL12/CXCR4 signal relay

In a project funded by the European Research Council, Weber is investigating the contribution of a class of signal proteins known as chemokines to the pathogenesis of atherosclerosis. Chemokines are small proteins released by various types of immune cells, which interact with specific found on the surfaces of other cells and modulate their function. One of the new papers is devoted to the action of the chemokine CXCL12. Binding of CXCL12 by its receptor CXCR4 plays a significant role in controlling the recruitment of to sites of tissue inflammation. The results reported demonstrate that the interaction between CXCL12 and CXCR4 serves to inhibit the development of atherosclerotic plaques. "We have shown, for the first time, that activation of the chemokine receptor CXCR4 in endothelial cells limits the progression of atherosclerosis," Weber says.

The researchers investigated the role of the signaling pathway by specifically inducing the deletion of the gene for the receptor in either the of the arteries or in the underlying smooth-muscle cells. In a mouse model, they found that the resulting depletion of the protein in either cell type stimulated the formation of atherosclerotic deposits. "As the amount of activated receptor falls, the more permeable the vessel wall becomes," as Dr. Yvonne Döring, first author of the paper, explains. This in turn enables pro-inflammatory cells to migrate into the underlying tissues. Taken together, these observations imply that CXCR4 is essential for maintenance of the integrity of the endothelial cell layer. In addition, loss of the receptor in smooth-muscle cells altered their character and reduced their contractile responses. Subsequent analyses of variants of naturally occurring CXCR4 gene variants in humans confirmed that reduced expression of the receptor is indeed associated with increased risk for coronary heart disease.

Cholesterol efflux and the MC1-R pathway

In a further study carried out at the IPEK, Professor Sabine Steffens and Dr. Petteri Rinne (who is now at Turku University in Finland) identified a novel function of the receptor MC1-R. MC1-R is best known for its role in activating synthesis of the pigment melanin in the skin, which acts as an endogenous sunscreen and protects against the mutagenic effects of UV radiation. However, the receptor has a variety of other functions. For example, it is thought to be involved in the regulation of inflammatory responses, which raises the question of whether it too might play a role in atherosclerosis. "MC1-R is expressed on the surface of macrophages," says Steffens (macrophages are the immune system's waste-disposal service; they ingest and dispose of dead and dying cells and other debris), "and we have now shown that it regulates so-called reverse cholesterol transport in these cells." Specifically, the study demonstrates that activation of MC1-R promotes the extrusion of excess cholesterol from the macrophages found within atherosclerotic lesions, and actively prevents its re-uptake. Conversely, inhibition of the MC1-R signal pathway stimulates the transport of cholesterol into macrophages.

These findings imply that, like CXCR4, MC1-R also inhibits the development of atherosclerosis. Excessive uptake of cholesterol converts macrophages into so-called foam cells, which are known to contribute to the inflammation reactions within . This in turn increases the risk that plaques may rupture and obstruct blood-flow, which can lead to a heart attack or a stroke.

Explore further: New PET radiotracer identifies inflammation in life-threatening atherosclerosis

More information: Yvonne Döring et al. Vascular CXCR4 Limits Atherosclerosis by Maintaining Arterial Integrity: Evidence from Mouse and Human Studies, Circulation (2017). DOI: 10.1161/CIRCULATIONAHA.117.027646

Petteri Rinne et al. Melanocortin 1 Receptor Signaling Regulates Cholesterol Transport in Macrophages, Circulation (2017). DOI: 10.1161/CIRCULATIONAHA.116.025889

Related Stories

New PET radiotracer identifies inflammation in life-threatening atherosclerosis

March 1, 2017
In the featured article of the March 2017 issue of The Journal of Nuclear Medicine, researchers demonstrate that a new positron emission tomography (PET) radiotracer, gallium-68 (Ga-68)-pentixafor, can quickly and non-invasively ...

Monocyte migrations

February 19, 2013
LMU researchers led by Christian Weber have, for the first time, elucidated how cells that promote the development of atherosclerosis find their way to the blood vessel wall, where they stimulate the formation of obstructive ...

Tailored intervention in acute and chronic inflammation

April 6, 2017
Signal molecules called chemokines often work in tandem to recruit specific sets of immune cells to sites of tissue damage. A systematic analysis of their interactions by researchers from Ludwig-Maximilians-Universitaet (LMU) ...

Promising and perilous? The ambivalent role of the CXCL12/ CXCR4 axis in heart repair

November 30, 2011
The chemokine CXCL12 acts as a chemical signal which mobilizes hematopoietic and other types of stem cells to leave the bone marrow and enter the circulation. Secretion of CXCL12 also guides these cells to sites at which ...

Endogenous peptide lowers cholesterol

January 19, 2017
Cells of the innate immune system that play an important role in development of atherosclerosis contain a protein that reduces levels of cholesterol in mice – and thus helps to inhibit or mitigate the disease.

Atherosclerosis—a short cut to inflammation

February 10, 2016
The enzyme Dicer processes RNA transcripts, cutting them into short segments that regulate the synthesis of specific proteins. An Ludwig-Maximilians-Universitaet (LMU) in Munich team has shown that Dicer promotes the development ...

Recommended for you

Mouse studies shed light on how protein controls heart failure

October 18, 2017
A new study on two specially bred strains of mice has illuminated how abnormal addition of the chemical phosphate to a specific heart muscle protein may sabotage the way the protein behaves in a cell, and may damage the way ...

Newborns with trisomy 13 or 18 benefit from heart surgery, study finds

October 18, 2017
Heart surgery significantly decreases in-hospital mortality among infants with either of two genetic disorders that cause severe physical and intellectual disabilities, according to a new study by a researcher at the Stanford ...

Saving hearts after heart attacks: Overexpression of a gene enhances repair of dead muscle

October 17, 2017
University of Alabama at Birmingham biomedical engineers report a significant advance in efforts to repair a damaged heart after a heart attack, using grafted heart-muscle cells to create a repair patch. The key was overexpressing ...

High blood pressure linked to common heart valve disorder

October 17, 2017
For the first time, a strong link has been established between high blood pressure and the most common heart valve disorder in high-income countries, by new research from The George Institute for Global Health at the University ...

Blood cancer gene could be key to preventing heart failure

October 16, 2017
A new study, published today in Circulation, shows that the gene Runx1 increases in damaged heart muscle after a heart attack. An international collaboration led by researchers from the University of Glasgow, found that mice ...

Mitochondrial DNA could predict risk for sudden cardiac death, heart disease

October 11, 2017
Johns Hopkins researchers report that the level, or "copy number," of mitochondrial DNA—genetic information stored not in a cell's nucleus but in the body's energy-creating mitochondria—is a novel and distinct biomarker ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.